Similar articles for PMID: 21879313

Year	Number of Results
2005	1
2006	2
2007	1
2009	1
2010	8
2011	30
2012	36
2013	26
2014	20
2015	14
2016	3
2017	3
2018	1
2019	1
2020	2
2021	3
2022	2
2024	0

1

Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C.

Aizawa Y, Yohizawa K, Aida Y, Ishiguro H, Abe H, Tsubota A. Aizawa Y, et al. Mol Cell Biochem. 2012 Jan;360(1-2):9-14. doi: 10.1007/s11010-011-1037-5. Epub 2011 Aug 31. Mol Cell Biochem. 2012. PMID: 21879313

2

Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b.

Yoshizawa K, Abe H, Aida Y, Ishiguro H, Ika M, Shimada N, Tsubota A, Aizawa Y. Yoshizawa K, et al. J Med Virol. 2013 Jul;85(7):1180-90. doi: 10.1002/jmv.23597. J Med Virol. 2013. PMID: 23918536

3

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Nakamura Y, Kumada H. Akuta N, et al. Hepatology. 2010 Aug;52(2):421-9. doi: 10.1002/hep.23690. Hepatology. 2010. PMID: 20648473

4

Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.

Toyoda H, Kumada T, Hayashi K, Honda T, Katano Y, Goto H, Kawaguchi T, Murakami Y, Matsuda F. Toyoda H, et al. J Med Virol. 2011 Sep;83(9):1559-64. doi: 10.1002/jmv.22145. J Med Virol. 2011. PMID: 21739446

5

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.

Maekawa S, Sakamoto M, Miura M, Kadokura M, Sueki R, Komase K, Shindo H, Komatsu N, Shindo K, Kanayama A, Ohmori T, Amemiya F, Takano S, Yamaguchi T, Nakayama Y, Kitamura T, Inoue T, Okada S, Enomoto N. Maekawa S, et al. Hepatology. 2012 Nov;56(5):1611-21. doi: 10.1002/hep.25826. Hepatology. 2012. PMID: 22577043

6

Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus.

Hiraga N, Abe H, Imamura M, Tsuge M, Takahashi S, Hayes CN, Ochi H, Tateno C, Yoshizato K, Nakamura Y, Kamatani N, Chayama K. Hiraga N, et al. Hepatology. 2011 Sep 2;54(3):764-71. doi: 10.1002/hep.24453. Epub 2011 Aug 2. Hepatology. 2011. PMID: 21618576

7

Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection.

Al-Qahtani A, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalaf N, Viswan N, Al-Ahdal MN. Al-Qahtani A, et al. J Immunol Res. 2015;2015:768470. doi: 10.1155/2015/768470. Epub 2015 Feb 25. J Immunol Res. 2015. PMID: 25811035 Free PMC article.

8

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.

Hayes CN, Kobayashi M, Akuta N, Suzuki F, Kumada H, Abe H, Miki D, Imamura M, Ochi H, Kamatani N, Nakamura Y, Chayama K. Hayes CN, et al. Gut. 2011 Feb;60(2):261-7. doi: 10.1136/gut.2010.223495. Epub 2010 Nov 10. Gut. 2011. PMID: 21068134

9

Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.

Toyoda H, Kumada T, Tada T, Kawaguchi T, Murakami Y, Matsuda F. Toyoda H, et al. J Med Virol. 2011 Jul;83(7):1203-11. doi: 10.1002/jmv.22092. J Med Virol. 2011. PMID: 21567424

10

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

Clark PJ, Thompson AJ, Zhu M, Vock DM, Zhu Q, Ge D, Patel K, Harrison SA, Urban TJ, Naggie S, Fellay J, Tillmann HL, Shianna K, Noviello S, Pedicone LD, Esteban R, Kwo P, Sulkowski MS, Afdhal N, Albrecht JK, Goldstein DB, McHutchison JG, Muir AJ; IDEAL investigators. Clark PJ, et al. J Viral Hepat. 2012 May;19(5):332-40. doi: 10.1111/j.1365-2893.2011.01553.x. Epub 2012 Feb 22. J Viral Hepat. 2012. PMID: 22497812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

130 results

Results by year